Zu "1310726-60-3" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Upadacitinib
Artikelnummer: TGM-T7503-100mg
Description: Upadacitinib (ABT-494) (ABT-494) is a selective Janus kinase (JAK) 1 inhibitor, which is being studied for the treatment of several autoimmune disorders in the IC50 of 43 nM. Target: JAK. Smiles: CC[C@@H]1CN(C[C@@H]1c1cnc2cnc3[nH]ccc3n12)C(=O)NCC(F)(F)F. References: Nakayamada S, et al. Recent Progress...
| Schlagworte: | ABT-494 |
| Anwendung: | Targets Janus kinase 1 [EC:2.7.10.2] (JAK1) |
| CAS | 1310726-60-3 |
| MW: | 380.37 D |
ab 40,00 €
Upadacitinib
Artikelnummer: Cay29706-1
Upadacitinib is a JAK1 inhibitor (IC50 = 47 nM). It is selective for JAK1 over JAK3 and tyrosine kinase 2 (Tyk2, IC50s = 2,304 and 4,690 nM, respectively), as well as a panel of 83 additional kinases at 1 µM, but does inhibit JAK2, Rho-associated kinase I (ROCK1), and ROCK2 (IC50s = 120, 920, and 430 nM,...
| Schlagworte: | ABT-494, (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide |
| Anwendung: | JAK1 inhibitor |
| CAS | 1310726-60-3 |
| MW: | 380.4 D |
ab 44,00 €
